MARKET

AXSM

AXSM

Axsome Therapeut
NASDAQ
220.89
+8.15
+3.83%
After Hours: 221.20 +0.31 +0.14% 19:34 08/10 EDT
OPEN
215.88
PREV CLOSE
212.74
HIGH
223.40
LOW
210.00
VOLUME
1.40M
TURNOVER
--
52 WEEK HIGH
260.19
52 WEEK LOW
102.67
MARKET CAP
11.37B
P/E (TTM)
-59.0757
1D
5D
1M
3M
1Y
5Y
1D
Axsome Therapeutics GAAP EPS of -$0.99 misses by $0.10, revenue of $218.4M misses by $3.38M
Seeking Alpha · 17h ago
*Axsome Therapeutics 2Q Rev $218.4M >AXSM
Dow Jones · 17h ago
Axsome Therapeutics Q2 EPS $(0.99) Misses $(0.83) Estimate, Sales $218.400M Miss $221.230M Estimate
Benzinga · 17h ago
*Axsome Therapeutics 2Q Loss/Shr 99c >AXSM
Dow Jones · 17h ago
Press Release: Axsome Therapeutics Reports Second -2-
Dow Jones · 17h ago
Press Release: Axsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Dow Jones · 17h ago
Weekly Report: what happened at AXSM last week (0803-0807)?
Weekly Report · 18h ago
These Are the Stocks Reporting Earnings Today – August 10, 2026
TipRanks · 20h ago
More
About AXSM
Axsome Therapeutics, Inc. is a fully integrated biopharmaceutical company. The Company focused on developing medicines for people impacted by central nervous system (CNS) conditions. Its commercial products include AUVELITY, SUNOSI, and SYMBRAVO. It is also advancing pipeline of novel product candidates in early- to late-stage development addressing a broad range of serious neurological and psychiatric conditions. Its product pipelines include AXS-05, AXS-12, and AXS-14. Its lead product candidate, AXS-05 (dextromethorphan-bupropion), is developed for the treatment of Alzheimer’s disease (AD) agitation and smoking cessation. Its AXS-12 (reboxetine) is a novel, oral, potent, highly selective investigational norepinephrine reuptake inhibitor (NRI) and cortical dopamine modulator being developed for the treatment of narcolepsy. Its AXS-14 (esreboxetine) is a novel, oral, potent, highly selective investigational NRI being developed for the management of fibromyalgia.

Webull offers Axsome Therapeutics Inc stock information, including NASDAQ: AXSM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AXSM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AXSM stock methods without spending real money on the virtual paper trading platform.